Prognostic significance of TP53 alterations in breast carcinoma.

by Andersen, T. I., Holm, R., Nesland, J. M., Heimdal, K. R., Ottestad, L., Børresen, A. L.
Published 1993

TP53 allele loss, mutations and expression in malignant melanoma.

by Flørenes, V. A., Oyjord, T., Holm, R., Skrede, M., Børresen, A. L., Nesland, J. M., Fodstad, O.
Published 1994

Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene status.

by Smith-Sørensen, B., Kaern, J., Holm, R., Dørum, A., Tropé, C., Børresen-Dale, A. L.
Published 1998

Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load.

by Helland, A., Karlsen, F., Due, E. U., Holm, R., Kristensen, G., Børresen-Dale, A. l.
Published 1998

TP53 gene mutations and protein accumulation in primary vaginal carcinomas.

by Skomedal, H., Kristensen, G., Helland, A., Nesland, J. M., Kooi, S., Børresen, A. L., Holm, R.
Published 1995

Analysis of p53, p16MTS, p21WAF1 and H-ras in archived bladder tumours from workers exposed to aromatic amines.

by Sørlie, T., Martel-Planche, G., Hainaut, P., Lewalter, J., Holm, R., Børresen-Dale, A. L., Montesano, R.
Published 1998

P53 mutations in gastric carcinomas.

by Seruca, R., David, L., Holm, R., Nesland, J. M., Fangan, B. M., Castedo, S., Sobrinho-Simões, M., Børresen, A. L.
Published 1992

Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas.

by Maelandsmo, G. M., Flørenes, V. A., Hovig, E., Oyjord, T., Engebraaten, O., Holm, R., Børresen, A. L., Fodstad, O.
Published 1996